Scotland co-ordinates major bowel cancer study:
This article was originally published in Clinica
Executive Summary
Scotland's Edinburgh University has announced the launch of what it claims is the largest European study of bowel cancer. The Medical Research Council is funding the £1.4 million ($2 million) project, under which every newly diagnosed case in the 16-79 year age group in Scotland over the next two to three years - an estimated 4,000 patients - will be studied. Researchers will screen DNA and white blood cells to assess the genetic basis of bowel cancer. Patients will be followed both during hospitalisation and after discharge, comparing those with and without a family history of the disease in each age group.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.